Health Condition 1: J459- Other and unspecified asthma
Conditions
Interventions
Intervention1: Individualized homoeopathic medicine based on BTPB: Patients fulfilling the inclusion and exclusion criteria will be enrolled in the study after obtaining written informed consent. Deta
Sponsors
Dr Shailender Singh Rawat
Eligibility
Inclusion criteria
Inclusion criteria: 1 Patients presenting with clinical signs and symptoms consistent with bronchial asthma 2 Patients with a confirmed diagnosis of bronchial asthma based on clinical history and or diagnostic tests 3 Patients on conventional treatment for bronchial asthma 4 Patients who are willing to participate and provide written informed consent
Exclusion criteria
Exclusion criteria: 1 Patients diagnosed with severe persistent asthma with significant restriction of daily activities 2 Patients experiencing status asthmaticus 3 Patients with serious complications or uncontrolled or life threatening systemic illnesses like cardiac failure or uncontrolled diabetes or renal or hepatic failure 4 Pregnant women and lactating mothers 5 Individuals with a history of substance abuse or dependence 6 Patients unwilling or unable to provide informed consent or participate in the study procedures 7 Individuals with a self reported immune compromised state like HIV or ongoing immunosuppressive therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of the study will be the change in the Asthma Control Test ACT score from baseline to the end of the study periodTimepoint: 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcome of the study will be assessed using the Asthma Quality of Life Questionnaire AQLQ S developed by Elizabeth JuniperTimepoint: Baseline to 6 months | — |
Countries
India
Contacts
Public ContactDr Shailender Singh Rawat
State National Homoeopathic Medical College And Hospital
Outcome results
None listed